UK Markets open in 3 hrs 41 mins

Addex Therapeutics Ltd (ADDXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.56000.0000 (0.00%)
At close: 9:55AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 550.58M
Enterprise value 335.5M
Trailing P/E N/A
Forward P/E 1-3.32
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)12.68
Price/book (mrq)2.57
Enterprise value/revenue 38.90
Enterprise value/EBITDA 7-2.77

Trading information

Stock price history

Beta (5Y monthly) 1.46
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 31.6500
52-week low 31.5600
50-day moving average 31.5600
200-day moving average 31.6244

Share statistics

Avg vol (3-month) 379
Avg vol (10-day) 3N/A
Shares outstanding 526.37M
Implied shares outstanding 6N/A
Float 14.03M
% held by insiders 17.00%
% held by institutions 131.50%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 0.00%
Operating margin (ttm)-317.18%

Management effectiveness

Return on assets (ttm)-35.39%
Return on equity (ttm)-72.50%

Income statement

Revenue (ttm)3.99M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)15.00%
Gross profit (ttm)-6.47M
EBITDA -12.81M
Net income avi to common (ttm)-12.77M
Diluted EPS (ttm)-0.4290
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.15M
Total cash per share (mrq)0.53
Total debt (mrq)420.16k
Total debt/equity (mrq)2.56
Current ratio (mrq)5.70
Book value per share (mrq)0.61

Cash flow statement

Operating cash flow (ttm)-11.07M
Levered free cash flow (ttm)-6.3M